Optimization of EMIT reagent system using a COBAS-BIO centrifugal analyzer

Area of Science:

• Clinical Chemistry
• Analytical Chemistry
• Biotechnology

Background:

• Theophylline drug monitoring is crucial for patient safety and therapeutic efficacy.
• Existing methods for theophylline analysis may have limitations in terms of cost, efficiency, or reagent consumption.

Purpose of the Study:

• To optimize the EMIT (Enzyme Multiplied Immunoassay Technique) reagent system for use with the COBAS-BIO centrifugal analyzer.
• To evaluate the precision, accuracy, and efficiency of the optimized method for theophylline determination.

Main Methods:

• Developed an optimized protocol for applying the EMIT reagent system to the COBAS-BIO centrifugal analyzer.
• Assayed 41 serum samples using the modified protocol and compared results with High-Performance Liquid Chromatography (HPLC) analysis.
• Performed regression analysis to correlate results from both methods.

Main Results:

• The optimized method demonstrated good precision and accuracy for theophylline measurement.
• Regression analysis showed a strong correlation between the COBAS-BIO centrifugal analyzer (EMIT) and HPLC methods (y = 1.10x + 0.01, r = 0.964).
• The modified protocol significantly minimized reagent consumption.

Conclusions:

• The COBAS-BIO centrifugal analyzer with the optimized EMIT methodology provides an efficient, inexpensive, and relatively effortless approach for routine drug monitoring.
• This optimized method is suitable for clinical laboratories seeking cost-effective and reliable theophylline analysis.